This paper analyses the role of inter-organisational trust in pharmaceutical biotechnology, all industry characterised by a strong dual market structure. Our main finding is that repeated ties in pairs of large pharmaceutical companies and small, entrepreneurial biotechnology firms, which indicate inter-organisational trust, have a negative effect on Subsequent partnering. An explanation for this result is found in specific conditions for R&D partnering in this high-technology dual market structure. Partnerships between a small number of very large companies and a large group of dependent small companies are not characterised by Mutual dependence and inter-organisational trust.
Hagedoorn, J., Roijakkers, A. H. W. M., & van Kranenburg, H. L. (2008). The formation of subsequent inter-firm R&D partnerships between large pharmaceutical companies and small, entrepreneurial biotechnology firms - How important is inter-organisational trust? International Journal of Technology Management, 44(1/2), 81-92. https://doi.org/10.1504/IJTM.2008.020699